Colucid Pharma Cmn (CLCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLCD | AVBP | MLTX | ||
| Company | Colucid Pharma Cmn | Arrivent Biopharma Inc | Moonlake Immunotherapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 46.50 | 22.33 | 13.82 | ||
| High | 46.55 | 22.81 | 13.82 | ||
| Low | 46.45 | 21.81 | 13.82 | ||
| Latest | 46.53 | 21.97 | 13.82 | ||
| Change | +0.03 | -0.32 | -0.01 | ||
| % Change | +0.06% | -1.44% | -0.07% | ||
| Volume | 127,000 | 215,300 | 7,144 | ||
| 20-Day Average Volume | 245,780 | 443,655 | 1,623,862 | ||
| Previous Close | 46.50 | 22.29 | 13.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 46.44 | 23.11 | 14.06 | ||
| 20-Day Raw Stochastic | 70.00% | 28.84% | 43.58% | ||
| 20-Day Relative Strength | 67.22 | 50.52 | 45.61 | ||
| Weighted Alpha | +162.70 | -11.73 | +74.38 | ||
| Today's Opinion | N/A | 64% Buy | 56% Sell | ||
| Previous Opinion | N/A | 64% Buy | 56% Sell | ||
| Last Month's Opinion | N/A | 8% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.06% since 02/21/17 | +3.78% since 12/18/25 | +3.21% since 12/19/25 | ||
| Low | 46.45 on 02/28/17 | 21.32 on 12/19/25 | 13.32 on 12/23/25 | ||
| High | 46.55 on 02/28/17 | 22.81 on 12/26/25 | 14.12 on 12/24/25 | ||
| 1-Month | |||||
| %Chg | +0.61% since 01/27/17 | -4.69% since 11/26/25 | +0.66% since 11/28/25 | ||
| Low | 46.20 on 01/30/17 | 20.41 on 12/03/25 | 12.48 on 12/02/25 | ||
| High | 46.65 on 02/08/17 | 25.82 on 12/08/25 | 15.56 on 12/08/25 | ||
| 3-Month | |||||
| %Chg | +37.26% since 11/28/16 | +21.85% since 09/26/25 | +121.30% since 09/29/25 | ||
| Low | 31.25 on 01/06/17 | 17.00 on 11/03/25 | 6.08 on 09/30/25 | ||
| High | 46.65 on 02/08/17 | 25.82 on 12/08/25 | 15.56 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +441.05% since 08/26/16 | -3.68% since 06/26/25 | -70.92% since 06/27/25 | ||
| Low | 8.65 on 08/29/16 | 16.10 on 08/12/25 | 5.95 on 09/29/25 | ||
| High | 46.65 on 02/08/17 | 25.82 on 12/08/25 | 62.75 on 09/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 897,098 | 906,943 | 888,315 | ||
| Shares Outstanding, K | 19,280 | 41,281 | 64,231 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -30,740,000 | -80,490,000 | -118,940,000 | ||
| Last Quarter Sales | N/A | 0 | 0 | ||
| Last Quarter Net Income | N/A | -34,980,000 | -69,730,000 | ||
| 60-Month Beta | 1.51 | 0.95 | 1.21 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.83 on 11/10/25 | -1.10 on 11/05/25 | ||
| Latest Earnings Date | 03/01/17 | 03/02/26 | 02/25/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||